Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the …
Neurodegenerative diseases pose a substantial socioeconomic burden on society.
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …
Unfortunately, the aging world population and lack of effective cures foreshadow a negative …
[HTML][HTML] Novel therapeutic approaches for Alzheimer's disease: an updated review
Alzheimer's disease (AD) is a progressive neurodegenerative disease and accounts for
most cases of dementia. The prevalence of AD has increased in the current rapidly aging …
most cases of dementia. The prevalence of AD has increased in the current rapidly aging …
[HTML][HTML] Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases
W Zhang, B Falcon, AG Murzin, J Fan, RA Crowther… - elife, 2019 - elifesciences.org
Assembly of microtubule-associated protein tau into filamentous inclusions underlies a
range of neurodegenerative diseases. Tau filaments adopt different conformations in …
range of neurodegenerative diseases. Tau filaments adopt different conformations in …
[HTML][HTML] Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders
Modern research has revealed that dietary consumption of flavonoids and flavonoids-rich
foods significantly improve cognitive capabilities, inhibit or delay the senescence process …
foods significantly improve cognitive capabilities, inhibit or delay the senescence process …
Tau pathology and neurodegeneration
MG Spillantini, M Goedert - The Lancet Neurology, 2013 - thelancet.com
The pathway leading from soluble and monomeric to hyperphosphorylated, insoluble and
filamentous tau protein is at the centre of many human neurodegenerative diseases …
filamentous tau protein is at the centre of many human neurodegenerative diseases …
[HTML][HTML] Alzheimer mechanisms and therapeutic strategies
There are still no effective treatments to prevent, halt, or reverse Alzheimer's disease, but
research advances over the past three decades could change this gloomy picture. Genetic …
research advances over the past three decades could change this gloomy picture. Genetic …
[HTML][HTML] A walk through tau therapeutic strategies
S Jadhav, J Avila, M Schöll, GG Kovacs… - Acta neuropathologica …, 2019 - Springer
Tau neuronal and glial pathologies drive the clinical presentation of Alzheimer's disease
and related human tauopathies. There is a growing body of evidence indicating that …
and related human tauopathies. There is a growing body of evidence indicating that …
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
M Jouanne, S Rault, AS Voisin-Chiret - European journal of medicinal …, 2017 - Elsevier
Alzheimer's Disease (AD) is a neurodegenerative brain disorder in which many biological
dysfunctions are involved. Among them, two main types of lesions were discovered and …
dysfunctions are involved. Among them, two main types of lesions were discovered and …
[HTML][HTML] The many faces of tau
While the microtubule-binding capacity of the protein tau has been known for many years,
new functions of tau in signaling and cytoskeletal organization have recently emerged. In …
new functions of tau in signaling and cytoskeletal organization have recently emerged. In …
[HTML][HTML] New insights into drug discovery targeting tau protein
Y Soeda, A Takashima - Frontiers in molecular neuroscience, 2020 - frontiersin.org
Microtubule-associated protein tau is characterized by the fact that it is an intrinsically
disordered protein due to its lack of a stable conformation and high flexibility. Intracellular …
disordered protein due to its lack of a stable conformation and high flexibility. Intracellular …